Clients

Emerald Health Therapeutics

Company Snapshot: Emerald Health Therapeutics

EMHTF
Last Change Volume High Low

Company Overview

Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF; Frankfurt: TBD) is a Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations and produces and sells dried cannabis and cannabis oil for medical purposes. Emerald owns 50% of Pure Sunfarms, which is converting a licensed existing 1.1 million square foot greenhouse in Delta, BC, and is in commercial production. It owns Agro-Biotech, a Québec-based licensed cannabis grower with a 75,000 square foot indoor facility and is planning to add a 500,000 square foot greenhouse in Metro Vancouver. Emerald’s team is highly experienced in life sciences, product development, large-scale agri-business, and marketing, and is focused on developing value- added cannabis-based products with potential wellness and medical benefits. Emerald is part of the Emerald Health group, which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.

Client News

  1. Aug 13 2019 Emerald Health Therapeutics’ Pure Sunfarms JV Reaches Q2 Sales of $32 Million, 78% EBITDA Margin, $0.65/Gram All-in Production Cost, and Third Consecutive Quarter of Profitability
  2. Aug 6 2019 Emerald Health Therapeutics Outlines Production and Processing Advancements
  3. Aug 6 2019 Emerald Health Therapeutics Outlines Production and Processing Advancements
  4. Aug 6 2019 Emerald Health Therapeutics Outlines Production and Processing Advancements
  5. Jul 30 2019 Emerald Health Therapeutics Appoints Chief Executive Officer